Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Buhl

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Current Opinion in Pulmonary Medicine|December 14, 2004
Anti-IgE antibodies for the treatment of asthmaRoland Buhl
Expert Opinion on Pharmacotherapy|July 25, 2003
Budesonide/formoterol for the treatment of asthmaRoland Buhl
Therapeutics and Clinical Risk Management|April 3, 2019
Future perspectives of anticholinergics for the treatment of asthma in adults and childrenRoland Buhl, Eckard Hamelmann
Medizinische Klinik (Munich, Germany : 1983)|May 20, 2008
[Lung cancer]Berthold Fischer, Roland Buhl
Respiration; International Review of Thoracic Diseases|December 12, 2019
Reply to the Letter Entitled "FeNO Variability when Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff"Stephanie Korn, Roland Buhl
International Journal of Chronic Obstructive Pulmonary Disease|November 3, 2012
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPDRoland Buhl, Donald Banerji
Pneumologie (Stuttgart, Germany)|August 24, 2023
[The new asthma guidelines for respiratory specialists 2023: companion and milestone in asthma care]Marek Lommatzsch, Roland Buhl
Respiratory Medicine|September 6, 2011
Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-studyStephanie Korn, Roland Buhl
Proceedings of the American Thoracic Society|August 23, 2005
Future directions in the pharmacologic therapy of chronic obstructive pulmonary diseaseRoland Buhl, Stephen G Farmer
The European Respiratory Journal|April 4, 2024
As-needed ICS/formoterol or as-needed SABA in mild asthma?Jerry A Krishnan, Roland Buhl
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Current Opinion in Pulmonary Medicine|December 14, 2004
Anti-IgE antibodies for the treatment of asthmaRoland Buhl
Expert Opinion on Pharmacotherapy|July 25, 2003
Budesonide/formoterol for the treatment of asthmaRoland Buhl
Therapeutics and Clinical Risk Management|April 3, 2019
Future perspectives of anticholinergics for the treatment of asthma in adults and childrenRoland Buhl, Eckard Hamelmann
Medizinische Klinik (Munich, Germany : 1983)|May 20, 2008
[Lung cancer]Berthold Fischer, Roland Buhl
Respiration; International Review of Thoracic Diseases|December 12, 2019
Reply to the Letter Entitled "FeNO Variability when Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff"Stephanie Korn, Roland Buhl
International Journal of Chronic Obstructive Pulmonary Disease|November 3, 2012
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPDRoland Buhl, Donald Banerji
Pneumologie (Stuttgart, Germany)|August 24, 2023
[The new asthma guidelines for respiratory specialists 2023: companion and milestone in asthma care]Marek Lommatzsch, Roland Buhl
Respiratory Medicine|September 6, 2011
Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-studyStephanie Korn, Roland Buhl
Proceedings of the American Thoracic Society|August 23, 2005
Future directions in the pharmacologic therapy of chronic obstructive pulmonary diseaseRoland Buhl, Stephen G Farmer
The European Respiratory Journal|April 4, 2024
As-needed ICS/formoterol or as-needed SABA in mild asthma?Jerry A Krishnan, Roland Buhl
Pageof 24